Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study.
Jeske van PamelenLynn van OlstAndries E Buddingnull nullElizabeth C M de LangeLeo H VisserPublished in: JMIR research protocols (2020)
DERR1-10.2196/16162.